Abstract
Introduction
Patients diagnosed with schizophrenia demonstrate a wide variety of clinical symptoms including hallucinations, delusions, formal thought disorder, and cognitive dysfunctions.
1, 2 Currently, diagnosing schizophrenia or evaluating the severity of the illness is determined based on clinical symptoms and an interview, without using objective biomarkers. 3 Biomarker refers to objective indications of medical state observed from outside the patient, which can be measured accurately and reproducibly. 4 Also, it can be used to diagnose the disease or to predict the severity of the illness. Establishing diagnosis without using objective information may sometimes lead to misdiagnosis, which is affected by some factors such as the race and sex of the patients, and even the experience of the clinician. 5, 6 In addition, psychotic symptoms cannot be easily determined based on an interview with the patients. 7 More objective biomarkers would be beneficial to help psychiatrists to diagnose and evaluate the illness. Many studies have tried to identify core pathological structural or functional changes in patients diagnosed with schizophrenia in order to establish biomarkers of the disease. 8, 9 While thousands of imaging studies have reported various structural as well as functional abnormalities in schizophrenia, these cannot be used as biomarkers at this time for several reasons: 1) some abnormalities are only present in some patients, 9 2) there is not a clear separation between patients and healthy controls because the range of values in all measures, when compared separately, are both wide and overlapping, and, 3) patients in each study show very heterogenous clinical characteristics.
According to several theories, schizophrenia should be considered a brain disease where subtle changes in various brain locations coexist. 10 Traditional univariate methods, which focus on gross differences in one structure at a group level, cannot detect widely distributed or subtle changes in the brain. 11 Because multiple measures have been introduced and reported to be abnormal in subsets of patients, and each explains only a small percentage of the variance, a multivariate approach should be considered for diagnosing schizophrenia using MRI. Furthermore, given the enormous number of values extracted from MRI images, machine learning approaches are needed to discriminate patients from healthy controls. Several such methods can be used to create classification models by means of pattern recognition of input data, i.e., linear discriminant analysis (LDA), support vector machine
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A C C E P T E D M A N U S C R I P T (SVM), and random forest (RF).
Some studies have previously been carried out to examine psychiatric diseases using T1, PET (positron emission tomography), or dMRI with SVM, LDA, or RF. 11, 12 The performance rate for predicting schizophrenia using imaging data varies, however, depending on the statistical method and the population of patients used. For example, studies using structural MRI report a performance rate that ranges from 54-91%. 13 providing better insight into the biological sense in the classification model; 2) RF is an ensemble of several decision trees and each tree is grown using a random subset of training sets and a random subset of features, which provides potential higher performance for the generalizations compared to decision tree; and, finally, 3) since RF produces non-linear decision boundaries due to the usage of decision tree, RF can outperform linear methods in capturing diverse patterns of structural or
A C C E P T E D M A N U S C R I P T There are few studies using diffusion measures on GM as a feature for classification method.
In this study, we evaluated the rate of performance for the classification of schizophrenia using the RF method and SVM method, with volume and dMRI measures in GM and WM as features, and we identified which structures were important for discriminating patients with schizophrenia from healthy controls.
A C C E P T E D M A N U S C R I P T
Materials and Methods

Participants and clinical variables
Subjects were enrolled from the Asan Medical Center, a university-affiliated hospital. Patients who were right-handed and were between the ages of 20-40 years old were eligible to participate in this study. Any patients with diseases that affect brain function were excluded. In addition, patients were excluded if they were unable to complete neuropsychological testing or MRI scanning sessions.
Subjects within the patient group had a diagnosis of schizophrenia, which was determined by a psychiatrist according to the Diagnostic and Statistical Manual of Mental Disorders-IV-Text Revision (DSM-IV-TR) criteria. Moreover, they also displayed psychotic symptoms such as delusions or hallucinations for less than 5 years. In addition, subjects in the control group did not have any Axis I psychiatric diagnosis themselves or any first-degree relatives with an Axis I psychiatric diagnosis.
We enrolled 91 subjects in the study, but 11 cases were excluded due to poor image quality or incidental brain lesions. Ten patients were additionally excluded because their diagnoses changed to other psychotic disorders, such as bipolar disorder, when they were re-evaluated 1-6 months after the initial enrollment. The final dataset, consisting of 70 subjects (patients: N=47; controls: N=23), was used for the analysis.
Written informed consent was obtained from all subjects. Ethical approval for the study was obtained from the local Institutional Review Board, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Assessment of symptoms and neurocognition
Assessment of symptoms, neurocognition, and social cognition was completed within one week of the date of the MRI examination. All subjects were evaluated using an age-and sex-adjusted short form of the Wechsler Adult Intelligence Scale-Third edition (WAIS-III), which consisted of 6 subtests including digit span, vocabulary, arithmetic, picture arrangement, block design, and digit symbol. The psychiatric symptoms of patients were evaluated by a psychiatrist using the Positive and Negative Syndrome Scale (PANSS).
MRI protocol and image processing
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MRI scans were performed using an 8 channel SENSE head coil on a 3 Tesla scanner (Philips Achieva 
Resampling, classification with random forest and support vector machine
Since our dataset was unbalanced, with the patient group about twice as large as that of the healthy control group, and classification with RF and SVM results may be biased by an unbalanced distribution of the sample, we resampled our data into a balanced dataset (46 patients and 46 controls) using the Synthetic Minority Oversampling Technique (SMOTE). 58 The SMOTE is one of the most popular methods for addressing the issue of unbalance and the general idea is to artificially generate cases of the minority class using K-nearest neighbors algorithm of these cases. In addition, to make a more balanced dataset, the majority class cases are also under-sampled.
58
Because there might be a chance of correlation among the features, we performed maximum
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A C C E P T E D M A N U S C R I P T relevance minimum redundancy (mRMR, feature selection method proposed by Peng et al.
59
) method to select the number of important features for classification from all features (N=504).
Then we gradually increased the number of features (N=1, 2, 3, …, 9, 10, 11, 31, 51, …, 491, 504) from the total number of features. After that, we performed learning and classification using these selected features and investigated the performance of later classification. (Fig.1a ) In addition, to test the statistical significance of the classification using RF and SVM, we randomly permuted the classification of all participants as a patient or healthy control 100 times and ran the RF and SVM with leave-one-out cross-validation (LOOCV, special case of k-cross validation when k is 92) for each permutation. (Fig. 1b) We then compared the sensitivity, and specificity of the original data set and the permuted data set.
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A C C E P T E D M A N U S C R I P T The parameters of RF used during the learning phase were as follows: number of trees (5000), number of features randomly selected at each node (square root of the number of features, 22 in our study), and size of the node (1). Size of the node in random forest is the minimal number of observations allowed in the terminal nodes of each tree, which indirectly limits the tree size in the RF method. The test sets were predicted to be a patient or a control using the model from the learning phase of the RF.
By comparing the real classification of participants (patient or healthy control) with the classification predicted by the RF and SVM, we calculated measures of performance such as sensitivity and specificity using the following formulas: sensitivity = (number of true positives) / (number of true positives + false negatives), specificity = (number of true negatives) / (number of true negatives + false positives). Since the RF generates the Out of Bag (OOB) error, we calculated the OOB error estimate.
Comparisons of volume, FA, and TR in important predictors between groups
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As described above, we sorted the importance of features using mRMR method. We summarized the list of 20 important features and compared their values between schizophrenia patients and healthy controls to verify that these features make biological sense.
Statistical analysis
All statistical analyses were performed using R (ver. 3.4.1) 60 , DMwR (ver. 0.4.1) for the SMOTE method, 61 random forest packages (ver. 4.6-12) 62 , and e1071 for SVM (ver. 1.6-8) 63 .
A C C E P T E D M A N U S C R I P T
Results
Summary of demographic and clinical characteristics
We enrolled 70 participants (23 healthy controls and 47 patients) in this study. mg/day (N=3). The duration of illness in the patients was 1.02 ± 1.58 years (Table 1) . 
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Permutation results
When the performance rate of the classification of the original group and the randomly permuted group were compared, the performance rate for the original group was significantly higher than the randomly permuted group (Table 2 and Fig. 3 ). 
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A C C E P T E D M A N U S C R I P T Fig. 3 Comparison of the distribution of performance between the original group and the randomly permuted group. The black lines indicate the mean and standard deviation of performance.
Abbreviations: OOB (Out-of-Bag)
Comparison values for significant predictors between the two groups
mRMR method showed the level of importance of all predictors in order to discriminate patients with schizophrenia from healthy controls. The values of the top 20 most important ROIs were compared using the Wilcoxon rank sum test between the two groups (Table 3) . 
Discussion
This study shows that patients with schizophrenia can be classified with high sensitivity and specificity by two different machine learning methods (RF and SVM) when 504 features from volume, FA, and TR of the brain structure are used, including GM, WM, and subcortical structures. Our study showed a high rate of performance (sensitivity: 87.6%, 89.5%; specificity: 95.9%, 94.5%; RF, SVM respectively), which is higher than the results found by meta-analysis. 26 Most studies of recent onset schizophrenia or firstepisode psychosis (FEP) reported 66-91.5% performance (sensitivity or specificity), 16, 17, 20, 23-25, 32, 33 which is lower than that with chronic schizophrenia. 26 Taking these previous studies into account, our results have more important implications. However, we should state that the application of our results to a general population of patients with schizophrenia should be carried out with caution since our small sample could not include all heterogeneous cases. Nonetheless studies that previously reported high performance (above 95% sensitivity) had even smaller sample sizes 28, 34, 35 although a recent review paper has raised a concern about the issue of generalizability of studies with small sample size reported high performance. 27 Larger study samples may include heterogeneous MRI information from both patients and healthy controls. Therefore, this increased heterogeneity can decrease the performance of the classification model.
Large training data sets, on the other hand, usually increase the performance of the classification system, and classification based on a small sample size is more unstable. 27 We could not find significant drop of overall performance rate when we repeatedly performed random forest with different numbers of features during the learning phase. We can assume that overfitting may therefore not significantly affect findings in our study.
We also tried to classify the cases using only MRI information. However, using MRI data alone may not be sufficient to classify cases in the early stages of the disease. Pina-Camacho et al. compared
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A C C E P T E D M A N U S C R I P T 67 Patients in our study also had a significantly lower IQ than healthy controls. Therefore, RF and SVM may be able to discriminate the cases with low IQ from the cases with high IQ, rather than discriminating subjects with schizophrenia from healthy controls. While it is not easy to control the effect of IQ on MRI, we regressed out IQ from all 504 features (volume, FA, and TR values). Then we ran 100 times LOOCV using RF with 504 features. Mean sensitivity and specificity was 82.8% and 92.7% respectively, which was slightly lower than those results (87.6% and 94.5%) of RF without adjustment of IQ. In addition to IQ, although there was no significant difference of age and gender between patients and healthy controls, these factors may be leading to overoptimistic estimates. The second limitation is that the structural differences that were used during the learning and classification phase may not be core pathological features of schizophrenia. Instead, these may be structural differences induced by several factors such as medications or life style. 68-71 Therefore, classification was carried out based on MRI differences that may not be related to core pathological changes. The last limitation is that, as previously mentioned, the sample size in our study was relatively small. The results in this study showed high prediction accuracy, while there was a chance that several confounding factors such as age, sex, medication or IQ might be leading to overoptimistic estimates. In addition, overfitting might happen during RF procedures due to relatively homogenous samples. Although we analyzed our sample data by cross-validation and permutation to overcome the problems, there is still a high risk of overfitting. It should be considered that even though the results showed high classification performance, their generalizability is limited. Our study used both volume and diffusion MRI data and performed RF method to discriminate patients with schizophrenia
A C C E P T E D M A N U S C R I P T from healthy controls. The results of this study should be considered preliminary and require further replications.
Conclusion
We were able to accurately discriminate the patients with recent onset schizophrenia from healthy controls using volume, FA, and TR of GM and WM with an RF and SVM methods. In order to generalize our results further, more studies are needed with larger sample sizes that include patients with heterogeneous symptoms.
